-
1-800 Flowers completes acquisition of Harry & David
Carle Place, N.Y. -- 1-800-Flowers.com announced the closing of its acquisition of Harry & David Holdings, a specialty retailer and producer of branded premium gift-quality fruit, gourmet food products and other gifts.
“This combination will propel our total annual revenues to more than $1.1 billion and offers numerous opportunities to accelerate our top and bottom-line growth going forward,” said Jim McCann, CEO of 1-800-Flowers.com.
-
Johnson & Johnson acquires biopharmaceutical company
Johnson & Johnson has entered into a definitive agreement to acquire Alios BioPharma, a privately held clinical stage biopharmaceutical company focused on developing therapies for viral diseases, for approximately $1.8 billion in cash.
The acquisition will include Alios BioPharma's portfolio of potential therapeutics for viral infections including compound AL-8176, an orally administered antiviral therapy currently in Phase 2 studies for the treatment of infants with respiratory syncytial virus.